glp-1 agonists are a type of medication you might need to take if you have type 2 diabetes. they are also known as glp-1 analogues, glp-1 ras and incretin mimetics.
glp-1 ras help slow ckd and lower heart disease risk for people with type 2 diabetes and/or obesity, but it’s important to weigh risks and benefits.
learn how glp-1 drugs work for diabetes and weight loss. explore glp-1 benefits, side effects, and emerging research on these medications....
pwc conducted a study on the future glp-1 market and the need for companies to reinvent their business models to adapt.
learn about glp-1 medications (i.e., mounjaro, ozempic, wegovy etc.) and eating disorders. visit the national eating disorders association.
glp-1 drugs are popular among people who want to lose weight. hear from a doctor about how glp-1s affect your health.
prescriptions for glp-1 weight loss medications like wegovy and ozempic can be purchased safely online. we picked the best ways to buy these glp-1 medications from legit sources.
learn about glp-1s (glucagon-like peptide-1 agonists) used for managing diabetes, weight loss, and cardiovascular health. discover the impact of rising demand and costs on employer plans,
supplements claiming to boost the body's natural glp-1 levels come in drops, pills and patches, but experts say they're most likely ineffective for weight loss.
recent guidelines recommend newer types of diabetes medications, and most americans are eligible.
some medicine for type 2 diabetes can improve blood sugar control and also may support weight loss.
“eat less, move more” is not a long-term weight management solution. but anti-obesity medications like glp-1 agonists can change a patient’s relationship with food so they can focus on creating healthy, sustainable habits.
glucagon-like peptide-1 receptor agonists (glp-1 agonists) are a newer class of medications that are fda-approved to manage type 2 diabetes and obesity in conjunction with diet and lifestyle changes.
this article serves as a go-to guide for understanding glp-1 medications, including how they work, their effectiveness, potential side effects, and who they might be a good fit for.
glp-1 medications, originally developed for type 2 diabetes management, are being studied for potential future uses beyond their current indications.
starting july 1, cvs caremark will stop covering eli lilly’s zepbound. wegovy, the glp-1 medication to treat obesity from lilly competitor novo nordisk, will still be covered under plans managed by cvs caremark.
drugs developed years ago to treat type 2 diabetes may not be safe and effective for patients with type 1 diabetes, researchers say.
learn about "ozempic face" and other side effects of glp-1 diabetes and weight-loss drugs....
glp-1 medications, such as semaglutide and liraglutide (brand names such as ozempic, wegovy and victoza, to name a few), are popular treatments for type 2 diabetes and obesity. these medications help control blood sugar and promote weight loss. however, recent studies show that they also may reduce the risk of a serious heart event.
glp-1s are a class of medications known to support blood sugar control and promote weight loss in adults with overweight or obesity. learn more.
glucagon-like peptide-1 receptor agonists are drugs that people use to manage type 2 diabetes. dr. maria prelipcean explains how they work, risks, and more.
social media is packed with claims of finding “nature’s ozempic.” how legitimate are these claims? get the facts about how food, fiber, “oatzempic,” supplements, and exercise affect glp-1.
glp-1 medications entered the u.s. pharmaceutical market in 2005. very recently, glp-1’s exploded in popularity as a type 2 diabetes drug designed to help the pancreas produce insulin. even more recently, other benefits were discovered for this drug, specifically appetite satiation, which leads to weight loss.
beyond shedding pounds, significant health benefits have emerged for heart disease, sleep apnea and other chronic diseases related to obesity.
watch our community q&a on glp-1’s and eating disorders with dr. kim dennis of suncloud health now. glp-1 medications & eating disorders after fielding questions about glp-1 medications from volunteers, group members, mentees, and on the helpline, anad has, with input from our clinical board members and scientific advisory board, assembled information relevant to anyone […]
five things you should know about using glp-1 drugs for weight loss
stanford psychiatrist anna lembke discusses what scientists have learned so far about the potential role of fda-approved glp-1 drugs in stemming addiction.
lay the foundation for understanding the high-cost drugs impacting pharmacy benefit plans today with this extensive history of glp-1s.
glp-1 agonist drugs for diabetes or weight loss may increase risks in surgery. learn how to protect yourself, including when to stop taking them before surgery.
nyu langone providers may prescribe medication in addition to lifestyle changes to help people living with obesity lose weight. learn more.
compounded semaglutide/tirzepatide will phase out by late may 2025, so prepare to switch to fda-approved products. here are the details.
how medicines called glucagon-like peptide 1 (glp-1) agonists help you to manage type 2 diabetes, together with healthy lifestyle changes.
glucagon-like peptide-1 (glp-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (t2dm) and obesity. as a class of medications, they are among several pharmacological options for these endocrine diseases. the function of glp-1 agonists is to lower serum glucose levels and thereby manage metabolism in affected patients. participating clinicians gain an enhanced understanding of when to prescribe these agonists, consider specific patient populations, and seek consultations with specialists in the care of their patients. recent recommendations regarding mixed formulations are also included in alignment with current research on this drug class. this activity will highlight the indications, mechanism of action, administration, adverse effect profile, and contraindications for these drugs. an interprofessional team of nurses, primary care clinicians, pharmacists, and endocrinologists remains pertinent to care for patients prescribed this class of medications.
with the popularity of glp-1 medications to treat obesity, providers need evidence-based resources to help educate and manage patient expectations.
kff’s latest health tracking poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. the poll finds 12% of adults report having taken one of these glp-1 drugs, which include ozempic, webovy and mounjaro. this includes 6% who say they are currently taking one of the drugs.
obesity specialist dr holly lofton reveals how she chooses the right glp-1 for each patient, and the importance of staying on label.
the real answer isn’t “yes” or “no.” here are six things you need to know.
a northwestern medicine obesity medicine physician discusses the impact of using synthetic glp-1 medications like semaglutide for weight management.
multiple glucagon-like peptide-1 (glp-1) agonist medications, created for the treatment of type 2 diabetes mellitus, are now labeled for the treatment of obesity. by activating glp-1 peptides, these medications affect body weight in many ways, including inhibiting glucagon and stimulating insulin release, and resulting in an average loss of 5% to 15% of body weight sustainable for at least 12 months.1–3
researchers got a surprise when they discovered people taking glp-1s were losing weight and reporting feeling fuller. the surprises keep coming – both welcome and worrisome.
ozempic® (semaglutide) injection is a once-weekly glp-1 ra medicine that, along with diet and exercise, may help improve blood sugar in adults with type 2 diabetes. read important safety information, including boxed warning.